1. A phase I, open-label, 2-part study to establish absolute bioavailability and the absorption, metabolism and excretion of evogliptin in healthy male subjects by a light-label approach. Issue 1 (January 2017) Authors: Song, Ji Su; Lee, Dae Young; Shim, Hyunjoo; Lee, Hee Joo; La, Sookie; Deuker, Stephen R.; Walker, Helen; Collier, Jo; Shaw, Iain Journal: Drug metabolism and pharmacokinetics Issue: Volume 32:Issue 1(2017)Supplement Page Start: S78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Absolute Bioavailability, Mass Balance, and Metabolic Profiling Assessment of [14C]‐Belumosudil in Healthy Men: A Phase 1, Open‐Label, 2‐Part Study. Issue 7 (1st March 2022) Authors: Schueller, Olivier; Skucas, Ed; Regev, Galit; Shaw, Iain; Singh, Nand; Sanghvi, Mitesh; Croft, Marie; Lohmer, Lauren; Alabanza, Anginelle; Patel, Jeegar Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 7(2022) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Absorption, metabolism and excretion of [14C]-gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans. Issue 1 (January 2017) Authors: Lee, Sung-Hack; Kim, Namtae; Ford, Gill; Wood, Stuart; Mair, Stuart; Walker, Helen; Shaw, Iain Journal: Drug metabolism and pharmacokinetics Issue: Volume 32:Issue 1(2017)Supplement Page Start: S78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Application of non-standard approaches to investigations of human mass balance and metabolite characterisation. Issue 1 (January 2019) Authors: Shaw, Iain; Helen, Walker; Scholes, Peter Journal: Drug metabolism and pharmacokinetics Issue: Volume 34:Issue 1(2019)Supplement Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P31 - Rates and routes of excretion of 14C-AQX-1125 following oral administration to rats, dogs and humans. (2020) Authors: Cooke, Ray; Bond, Philip; Barton, Eleanor; Shaw, Iain; Tam, Patrick; Toews, Judy; Harwig, Curtis; Pettigrew, Jeremy; Scholl, Dorothea; Padania, Sapna; Mackenzie, Lloyd Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P46 - Understanding the excretion profile and the metabolism of pitolisant in CYP450 2D6 poor and extensive metabolisers at steady state. (2020) Authors: Shaw, Iain; Robert, Philippe; Piris, Stephane; Duvauchelle, Thierry; Mair, Stuart; Walker, Helen; Wood, Stuart Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P47 - An integrated radiolabelled study to determine the absorption, metabolism, excretion and absolute bioavailability of pemafibrate in healthy male subjects. (2020) Authors: Shaw, Iain; Hounslow, Neil; Mair, Stuart; Walker, Helen; Wood, Stuart Journal: Drug metabolism and pharmacokinetics Issue: Volume 35(2020)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics and Metabolism of Ziritaxestat (GLPG1690) in Healthy Male Volunteers Following Intravenous and Oral Administration. Issue 2 (11th October 2021) Authors: Helmer, Eric; Willson, Ashley; Brearley, Christopher; Westerhof, Mark; Delage, Stephane; Shaw, Iain; Cooke, Ray; Sidhu, Sharan Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 2(2022) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗